What's new this month in BMJ JournalsBMJ 2005; 331 doi: https://doi.org/10.1136/bmj.331.7526.1168 (Published 17 November 2005) Cite this as: BMJ 2005;331:1168
- Harvey Marcovitch (firstname.lastname@example.org), BMJ syndication editor
Plantar fasciitis may respond to botulinum toxin
An open pilot study in nine patients with chronic plantar fasciitis suggests that botulinum toxin A may prove to be a useful treatment. The patients, whose symptoms had lasted 2-36 (mean 14) months, were given 200 units of the preparation, formulated as Dysport. Pain at rest had diminished substantially at two week follow-up, with the improvement being maintained at one year. No adverse event was encountered. The authors, from Berlin, now intend to conduct a randomised controlled trial.
Ann Rheum Dis 2005;64: 1659-61
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial